• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » CMS recommends postponing most elective procedures

CMS recommends postponing most elective procedures

March 19, 2020 By Nancy Crotti

The Centers for Medicare and Medicaid Services (CMS) released guidance late yesterday asking healthcare providers to postpone adult elective surgeries and procedures, including dental procedures, until further notice.

The move is an attempt to preserve the supply of ventilators and personal protective equipment such as masks and gowns while protecting patients and staff from exposure to the coronavirus. Dental exams in particular, which put the patient and provider in close proximity, pose one of the highest risks of transmission of the virus, and also deplete the supply of personal protective equipment, the agency said.

“Decisions remain the responsibility of local healthcare delivery systems, including state and local health officials, and those surgeons who have direct responsibility to their patients,” the agency said. “However, in analyzing the risk and benefit of any planned procedure, not only must the clinical situation be evaluated, but resource conservation must also be considered.”

CMS divided the types of procedures and its recommendations for those procedures into tiers. (See chart below.) Tier 1 includes outpatient and low-acuity procedures the agency recommends postponing, while Tiers 2 and 3 are for progressively more acute conditions.

Certain medtech firms will be harder hit than others given the new recommendations. Needham & Co. analyst Mike Matson said in an email that among the companies his firm covers, sacral modulation company Axonics Modulation Technologies (NSDQ:AXNX) and Cantel Medical (NYSE:CMD), which makes disposable products for endoscopies, will be most exposed to cutbacks on procedures in tiers 1 and 2.

Companies specializing in devices for higher-acuity procedures, including cardiovascular device firms  AtriCure (NSDQ:ATRC), CryoLife Inc. (NYSE:CRY) and Cardiovascular Systems (NSDQ:CSII) might feel the pinch from cutbacks in the higher-tiered procedures, Matson said. Larger companies with broader product lines are exposed to a range of procedures and it is difficult to quantify the mix, he added.

CMS said the recommendations might change as the outbreak unfolds. “At all times, the supply of personal protective equipment (PPE), hospital and intensive care unit beds, and ventilators should be considered, even in areas that are not currently dealing with COVID-19 infections,” the agency added.

CMS recommended that hospitals and healthcare providers consider the following factors when deciding whether elective surgery should proceed:

    • Current and projected COVID-19 cases in the facility and region.
    • The supply of personal protective equipment to the facilities in a particular healthcare system.
    • Staff availability.
    • Bed availability, especially intensive care unit (ICU) beds.
    • Ventilator availability.
    • Health and age of the patient, especially given the risks of concurrent COVID-19infection during recovery.
    • Urgency of the procedure.

CMS recommended decisions about procedures be made in consultation with the hospital, surgeon, patient and other public health professionals. The agency made up this chart to guide decision-making:

Tiers Action Definition Locations Examples
Tier 1a Postpone surgery/procedure Low acuity surgery/healthy patient
Outpatient surgery
Not life-threatening illness
HOPD*
ASC**
Hospital with low/no COVID-19 census
Carpal tunnel release
EGD
Colonoscopy
Cataracts
Tier 1b Postpone surgery/procedure Low acuity surgery/unhealthy patient HOPD
ASC
Hospital with low/no COVID-19 census
Endoscopies
Tier 2a Consider postponing surgery/procedure Intermediate acuity surgery/healthy patient
Not life-threatening but potential for future morbidity and mortality.
Requires in-hospital stay
HOPD
ASC
Hospital with low/no COVID-19 census
Low risk cancer
Non-urgent spine & ortho: including hip, knee replacement and elective spine surgery
Stable ureteral colic
Elective angioplasty
Tier 2b Postpone surgery/procedure if possible Intermediate acuity surgery/unhealthy patient HOPD
ASC
Hospital with low/no COVID-19 census
Tier 3a Do not postpone High acuity surgery/healthy patient Hospital Most cancers
Neurosurgery
Highly symptomatic patients
Tier 3b Do not postpone High acuity surgery/unhealthy patient Hospital Transplants
Trauma
Cardiac with symptoms
Limb threatening vascular surgery

*Hospital Outpatient Department

** Ambulatory Surgery Center

Filed Under: Cardiovascular, Cosmetic/Aesthetic, Dental, Endoscopic, Featured, Hospital Care, Medicare, Neurological, Oncology, Optical/Ophthalmic, Orthopedics, Otolaryngology/Ear, Nose & Throat (ENT), Surgical, Transplants, Vascular Tagged With: Centers for Medicare and Medicaid Services (CMS), coronavirus

More recent news

  • Medtronic escapes $106.5M payment in Colibri TAVR patent suit after court overturns jury verdict
  • RadNet closes iCAD acquisition, expands AI breast‑imaging portfolio
  • Hyperfine reports first commercial sales of next-gen AI-powered Swoop
  • Stereotaxis announces $12.5M offering
  • Nuwellis ends clinical trial of its ultrafiltration tech for heart failure

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy